A Three-Year Cross-Sectional Analysis of Depression, Anxiety, and Quality of Life in Patients with Post-COVID-19 Syndrome
- PMID: 38476627
- PMCID: PMC10929241
- DOI: 10.2147/IJGM.S453247
A Three-Year Cross-Sectional Analysis of Depression, Anxiety, and Quality of Life in Patients with Post-COVID-19 Syndrome
Abstract
Background: This study explores the longitudinal psychosocial impact of Long-COVID syndrome, also known as Post-COVID-19 syndrome, characterized by enduring symptoms after coronavirus disease (COVID-19) infection, over the years 2020, 2021, and 2022. It aimed to examine the variations in depression, anxiety, and quality of life among Post-COVID-19 patients during these years, hypothesizing significant inter-year differences reflecting the pandemic's evolving influence.
Methods: Conducted at Victor Babes Hospital for Infectious Diseases and Pulmonology, Romania, this cross-sectional research involved 324 patients diagnosed with mild to moderate COVID-19, assessed six months post-hospitalization. Standardized instruments, namely Short Form (SF-36) for quality of life, Generalised Anxiety Disorder Assessment (GAD-7) for anxiety, and Patient Health Questionnaire (PHQ-9) for depression, were utilized.
Results: The study observed a consistent average patient age of around 55 years across the years. A notable increase in COVID-19 vaccination rates was recorded, rising from 20.9% in 2020 to over 70% in 2022 (p<0.001). Trends in key post-COVID symptoms like fatigue and cognitive issues varied over the years. Importantly, there was a consistent decrease in feelings of sadness or depression, with scores declining from 7.3 in 2020 to 4.8 in 2022 (p<0.001). The SF-36 survey indicated a steady improvement in overall health, reaching 55.8±7.1 in 2022 (p=0.035). Both GAD-7 and PHQ-9 scores showed significant reductions in anxiety and depression over the years, with p-values of 0.030 and 0.031, respectively. Factors such as smoking status, substance use, and the initial severity of COVID-19 infection were significantly associated with depression levels.
Conclusion: The findings suggest that despite persistent physical symptoms, Long-COVID patients experienced enhancements in mental well-being and quality of life over the studied period. The increasing vaccination rates might have contributed to this improvement. Addressing modifiable risk factors like smoking and substance use could further optimize post-COVID care and mental health outcomes.
Keywords: COVID-19; SARS-CoV-2; long-COVID; post, acute COVID; quality of life.
© 2024 Bota et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Assessing the Quality of Life, Coping Strategies, Anxiety and Depression Levels in Patients with Long-COVID-19 Syndrome: A Six-Month Follow-Up Study.Diseases. 2024 Jan 11;12(1):21. doi: 10.3390/diseases12010021. Diseases. 2024. PMID: 38248372 Free PMC article.
-
Fatigue and Mental Illness Symptoms in Long COVID: Protocol for a Prospective Cohort Multicenter Observational Study.JMIR Res Protoc. 2024 Jan 19;13:e51820. doi: 10.2196/51820. JMIR Res Protoc. 2024. PMID: 38241071 Free PMC article.
-
What Proportion of Patients With Musculoskeletal Sarcomas Demostrate Symptoms of Depression or Anxiety?Clin Orthop Relat Res. 2022 Nov 1;480(11):2148-2160. doi: 10.1097/CORR.0000000000002295. Epub 2022 Jun 30. Clin Orthop Relat Res. 2022. PMID: 35901433 Free PMC article.
-
Pandemic Stressors and Adaptive Responses: A Longitudinal Analysis of the Quality of Life and Psychosocial Dynamics among Urothelial Cancer Patients.J Pers Med. 2023 Oct 28;13(11):1547. doi: 10.3390/jpm13111547. J Pers Med. 2023. PMID: 38003862 Free PMC article.
-
The association of mindfulness and psychological well-being among individuals who have recovered from COVID-19 in Jianghan District, Wuhan, China: A cross-sectional study.J Affect Disord. 2022 Dec 15;319:437-445. doi: 10.1016/j.jad.2022.09.062. Epub 2022 Sep 23. J Affect Disord. 2022. PMID: 36162667 Free PMC article.
Cited by
-
Factors associated with cognitive impairment and the quality-of-life among COVID-19 survivors working as healthcare workers.Narra J. 2024 Apr;4(1):e658. doi: 10.52225/narra.v4i1.658. Epub 2024 Mar 20. Narra J. 2024. PMID: 38798859 Free PMC article.
References
-
- Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020;179:85–100. PMID: 32971147; PMCID: PMC7505773. doi:10.1016/j.biochi.2020.09.018 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous